4-Amino-6-chloropicolinic acid

Catalog No.: 
ACGMKO152
CAS No.: 
546141-56-4
Molecular Formula: 
C6H5ClN2O2
Molecular Weight: 
172.57
4-Amino-6-chloropicolinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$74.00In stockInquiry
1g98%$202.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Amino-6-chloropicolinic acid
IUPAC Name4-amino-6-chloropicolinic acid
MDL No.MFCD13188880
Molecular FormulaC6H5ClN2O2
Molecular Weight172.57
SMILESO=C(O)C1=NC(Cl)=CC(N)=C1
InChI KeySSSUQLVGYOIGIX-UHFFFAOYSA-N
SynonymSCHEMBL16030719 | EN300-176986 | CS-0199443 | DTXSID00678182 | 2-Pyridinecarboxylic acid, 4-amino-6-chloro | 4-amino-6-chloropicolinicacid | AB67311 | AKOS022173458 | AM20061307 | BS-50013 | MFCD13188880 | SY284176 | 4-amino-6-chloro-2-pyridinecarboxylic
CAS No.546141-56-4
PubChem CID49760379

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330-P501

Synthetic Route by SureRoute

1. ACGMKO152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUNOP291 route compound structure diagram
    ACUNOP2911235475-17-8In Stock
  2. Then
  3. ACGMKO152 route product structure diagram
    ACGMKO152546141-56-4In Stock
Inquiry

2. ACGMKO152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. ACXLTJ136 route compound structure diagram
    ACXLTJ13688912-25-8In Stock
  4. Then
  5. ACGMKO152 route product structure diagram
    ACGMKO152546141-56-4In Stock
Inquiry

3. ACGMKO152 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGMKO152 route product structure diagram
    ACGMKO152546141-56-4In Stock
Inquiry

Comments (0)